Pulmonary infections in the HIV-infected patient in the era of highly active antiretroviral therapy: an update (Q48471992)

11 February 2018

title

Pulmonary infections in the HIV-infected patient in the era of highly active antiretroviral therapy: an update (English)

1 reference

11 February 2018

main subject

anti-retroviral agent

0 references

1 reference

Deepa G Lazarous

1

1 reference

11 February 2018

Anne E O'Donnell

series ordinal

2

1 reference

11 February 2018

publication date

1 May 2007

1 reference

11 February 2018

Current infectious disease reports

published in

1 reference

11 February 2018

volume

9

1 reference

11 February 2018

issue

3

1 reference

11 February 2018

page(s)

228-232

1 reference

11 February 2018

CD4 receptor-dependent entry of human immunodeficiency virus type-1 env-pseudotypes into CCR5-, CCR3-, and CXCR4-expressing human alveolar macrophages is preferentially mediated by the CCR5 coreceptor

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-007-0036-X

Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-007-0036-X

Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination

21 January 2018

1 reference

12 December 2020

Immune restoration disorders following HAART

1 reference

12 December 2020

Discontinuation of Secondary Prophylaxis againstPneumocystis cariniiPneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy

1 reference

12 December 2020

Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy

1 reference

12 December 2020

Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy.

1 reference

12 December 2020

Pneumocystis carinii pneumonia in HIV-infected patients in the HAART era.

1 reference

12 December 2020

Bacterial pneumonia in HIV-infected patients: analysis of risk factors and prognostic indicators

1 reference

12 December 2020

Immune reconstitution in HIV-infected patients

1 reference

12 December 2020

Patterns of chemokine receptor fusion cofactor utilization by human immunodeficiency virus type 1 variants from the lungs and blood.

1 reference

12 December 2020

Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia

1 reference

12 December 2020

A Randomized Trial of the Discontinuation of Primary and Secondary Prophylaxis againstPneumocystis cariniiPneumonia after Highly Active Antiretroviral Therapy in Patients with HIV Infection

1 reference

12 December 2020

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

12 December 2020

An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms.

1 reference

12 December 2020

Clinical indicators of immune restoration following highly active antiretroviral therapy

1 reference

12 December 2020

Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection

1 reference

12 December 2020

Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention

1 reference

12 December 2020

Tuberculosis in patients with human immunodeficiency virus infection

1 reference

12 December 2020

Global strategies to prevent bacterial pneumonia in adults with HIV disease

1 reference

12 December 2020

Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy

1 reference

12 December 2020

Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections

1 reference

12 December 2020

Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort

1 reference

12 December 2020

Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group

1 reference

12 December 2020

The relationship between cytomegalovirus retrieved by bronchoalveolar lavage and mortality in patients with HIV

1 reference

12 December 2020

Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia

1 reference

12 December 2020

Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men--New York City and California

1 reference

12 December 2020

Pulmonary complications of HIV infection. Report of the Fourth NHLBI Workshop

1 reference

12 December 2020

Pulmonary manifestations of HIV infection in the era of highly active antiretroviral therapy

1 reference

12 December 2020

1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with Human Immunodeficiency Virus. USPHS/IDSA Prevention of Opportunistic Infections Working Group. Infectious Diseases Society of American

1 reference

12 December 2020

Discontinuation of Primary Prophylaxis againstPneumocystis cariniiPneumonia in HIV-1–Infected Adults Treated with Combination Antiretroviral Therapy

1 reference

12 December 2020

The significance of the detection of cytomegalovirus in the bronchoalveolar lavage fluid in AIDS patients with pneumonia

1 reference

12 December 2020

Effect of Combination Therapy Including Protease Inhibitors on Mortality among Children and Adolescents Infected with HIV-1

1 reference

12 December 2020

Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.

1 reference

12 December 2020

Intensive Care of Patients with HIV Infection

1 reference

12 December 2020

Immunorestitution disease involving the innate and adaptive response

1 reference

12 December 2020

Improved survival for HIV infected patients with severe Pneumocystis jirovecii pneumonia is independent of highly active antiretroviral therapy

1 reference

12 December 2020

Infectious lung complications in patients with HIV/AIDS.

1 reference

12 December 2020

Clinical features and outcomes of HIV-related cytomegalovirus pneumonia

1 reference

12 December 2020

Incidence of Tuberculosis among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North America

1 reference

12 December 2020

Critical care of immunocompromised patients: human immunodeficiency virus

1 reference

12 December 2020

Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia.

1 reference

12 December 2020

10.1007/S11908-007-0036-X

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018